Maximum quantity allowed is 999
请选择数量
CAS RN: 51781-21-6 | 产品编码: C3015
Carteolol Hydrochloride
×
![]()
×
| 规格 | 单价 | 同一天 | 2-3个工作日 | 数量 |
|---|---|---|---|---|
| 50MG |
S$184.50
|
10 | 30 |
|
| 250MG |
S$669.00
|
9 | 25 |
|
| 产品编码 | C3015 |
| 纯度/分析方法 | >98.0%(T)(HPLC) |
| 分子式/分子量 | C__1__6H__2__4N__2O__3·HCl = 328.84 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 室温 (15°C以下阴凉干燥处) |
| 包装和容器 | 50MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 51781-21-6 |
| 相关CAS RN | 51781-06-7 |
| Reaxys-RN | 5784965 |
| PubChem物质ID | 253662438 |
| Merck Index (14) | 1866 |
| MDL编号 | MFCD00941499 |
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
物性（参考值）
| 熔点 | 278 °C |
| 水溶性 | 可溶 |
| 溶解性（微溶于） | 甲醇 |
| 溶解性（不溶于） | 乙醇, 乙醚 |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H302 : Harmful if swallowed. H361 : Suspected of damaging fertility or the unborn child. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P405 : Store locked up. |
相关法规
| RTECS# | VC8282000 |
运输信息
| HS编码* | 2933.79-000 |
应用
Carteolol Hydrochloride: A Nonselective β-Adrenoceptor Antagonist (Blocker)
Carteolol hydrochloride (OPC-1085) is a nonselective β-adrenoceptor antagonist (blocker) with intrinsic sympathomimetic activity (ISA). Carteolol effectively reduces intraocular pressure (IOP), and is used for the treatment of glaucoma. Recently, some formulations for ocular controlled delivery of carteolol hydrochloride have been developed. (The product is for research purpose only.)
References
- Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent β-adrenergic blocking agent
- Cellular and molecular remodeling in a heart failure model treated with the β-blocker carteolol
- Metabolism of carteolol by cDNA-expressed human cytochrome P450
- Comparison of the analysis of β-blockers by different techniques
- Poly(ε-caprolactone) nanocapsules in carteolol ophthalmic delivery
- Designing dendrimers for ocular drug delivery
参考文献
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。